This page sets out the terms and conditions of use for the CHBOI Toolkit
The National Clinical Trials Governance Framework Committees were convened comprising members with relevant expertise and experience in the clinical trials sector.
Reducing avoidable hospital readmissions supports better health outcomes, improves patient safety and leads to greater efficiency in the health system.
Based on advice, feedback and discussions with clinical experts and health services from across Australia, the Commission has compiled a list of FAQs and resources that may assist health services in the prevention and reduction of hospital-acquired complications (HACs).
Explore these resources and share your feedback.
Two groupers have been developed to support the implementation of the hospital-acquired complications (HACs) list. These tools that can be used by hospitals, health services and system managers to identify and monitor HACs.
Development of the HACs list involved a literature review, environmental scan, clinician-driven reports, a proof-of-concept study and subsequent refinements.
The Governance Framework embeds clinical trials into routine health service provision and strengthens the clinical and corporate governance arrangements for governments, hospital administrators, health services, private companies, trial sponsors and trial investigators.
The Classification of Hospital Acquired Diagnoses (CHADx) allows hospitals to identify, count and monitor adverse events that occur in hospital to support safety improvement efforts.
Well-designed incident management systems assist patients, carers, families and the workforce to identify, report, manage and learn from incidents.
A hospital-acquired complication (HAC) refers to a complication for which clinical risk mitigation strategies may reduce (but not necessarily eliminate) the risk of that complication occurring.